(Q35750719)

10 August 2017

1 reference

title

Update on oral treatments for male erectile dysfunction (English)

1 reference

10 August 2017

Kalsi JS

1

1 reference

PubMed ID

15096134

10 August 2017

Kell PD

series ordinal

2

1 reference

10 August 2017

1 May 2004

1 reference

Journal of the European Academy of Dermatology and Venereology

10 August 2017

1 reference

10 August 2017

18

1 reference

10 August 2017

3

1 reference

10 August 2017

267-274

1 reference

The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Erectile dysfunction in general medicine practice: prevalence and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Central control of erection and its pharmacological modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Evidence of an incerto-hypothalamic dopamine neurone system in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Origin and termination of the diencephalo-spinal dopamine system in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Systemic or intracranial apomorphine increases copulation in long-term castrated male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

The nitric oxide and cGMP signal transduction system: regulation and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Quality of life in patients with spinal cord injury receiving Viagra (sildenafil citrate) for the treatment of erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Sildenafil citrate (VIAGRA) improves erectile function in elderly patients with erectile dysfunction: a subgroup analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Efficacy of sildenafil in erectile dysfunction after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Efficacy, safety, and use of sildenafil in urologic practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

IC351 (tadalafil, Cialis): update on clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Vasomax for the treatment of male erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Yohimbine in erectile dysfunction: the facts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Apomorphine in the evaluation of dopaminergic function in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Efficacy of apomorphine SL in erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2004.00885.X

10.1111/J.1468-3083.2004.00885.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15096134